Gewählte Publikation:
Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Reiter, E; Mannhalter, C; Lechner, K; Leitner, G; Greinix, HT.
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.
Br J Haematol. 1997; 97(1):161-164
Doi: 10.1046/j.1365-2141.1997.262674.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
We present a patient who underwent sibling allogeneic BMT because of refractory Ph+ve ALL and remained BCR-ABL-positive after marrow grafting. Haemopoietic precursor cells were predominantly BCR-ABL-negative and of donor origin. In T cells an exclusively donor genotype was demonstrated. Despite donor leucocyte infusion (DLI), 20 weeks after BMT BCR-ABL fusion mRNA increased in semiquantitative polymerase chain reaction and leukaemic infiltration of the patient's bone marrow was seen. After a second course of DLI the patient achieved sustained molecular remission but he developed severe graft-versus-host disease (GvHD) and died from bacterial sepsis 9 months after DLI.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Bone Marrow Transplantation - methods
-
Fatal Outcome -
-
Humans -
-
Leukocyte Transfusion - methods
-
Male -
-
Neoplasm, Residual -
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
-
Recurrence -
-
Transplantation Chimera -
-
Transplantation, Homologous -
- Find related publications in this database (Keywords)
-
allogeneic marrow transplantation
-
Ph+ve ALL
-
donor leucocyte infusion